Frederic A.Oest

Associate

Düsseldorf + 49.211.5406.5500

Connect:

Share

Frederic Oest's practice focuses primarily on banking law and financing matters, including real estate finance. He also advises clients on the legal aspects of financial regulatory matters and investment companies on the management of investment funds in accordance with the supervisory regulation requirements for pension funds and insurers.

Frederic has advised, among others, national and international clients on matters related to real estate, project, and acquisition financing as well as financial restructurings. He has advised companies on the acquisition and financing of real estate portfolios in Europe and financial institutions on real estate and project financings around the world (including an international banking consortium on the €1.2 billion financing of an offshore wind farm).

He also advised a leading B2B direct bank on the acquisition of all securities accounts of a German bank.

In addition, Frederic has been part of the core team in several investigations conducted by the Firm.

Frederic was named "Ones to watch — lawyer of the future" in the legal directory Handelsblatt 2020/2021/2022.

Prior to joining Jones Day, Frederic worked in the banking & finance area for a leading international law firm in Düsseldorf and Munich.

Experience

  • Belfius Bank, ING Belgium, and KBC Bank amend, increase, and extend existing financing to Equine Care GroupJones Day acted as counsel to Belfius Bank SA/NV, ING Belgium NV/SA and KBC Bank NV, as lenders, in connection with the amendment, increase, and extension of the existing financing granted to the Equine Care Group (an international provider of high-quality equine care through specialist equine clinics, ambulatory care and nutrition/supplements) for the purpose of, amongst others, acquiring the Irish company Thoroughbred Remedies Manufacturing Limited and the English company Equine Products U.K. Limited.
  • BNP Paribas Fortis, Belfius Bank, KBC Bank, and ING Belgium provide €400 million revolving credit facility to SD Worx GroupJones Day acted as legal counsel to BNP Paribas Fortis NV/SA, Belfius Bank NV/SA, KBC Bank NV, and ING Belgium NV/SA in connection with the amendment, restatement, and increase of the revolving credit facility originally dated April 4, 2022 from €250 million to €400 million granted to SD Worx NV.
  • Diebold Nixdorf obtains $1.25 billion senior secured exit credit facilityJones Day represented Diebold Nixdorf, Incorporated, a multinational financial and retail technology company that specializes in the sale, manufacture, installation, and service of self-service transaction systems (such as ATMs and currency processing systems), point-of-sale terminals, physical security products, and software and related services for global financial, retail, and commercial markets, in connection with a new $1.25 billion senior secured term loan facility as part of it’s emergence from chapter 11 bankruptcy and other domestic and foreign court-supervised restructuring proceedings.
  • Diebold Nixdorf successfully restructures over $2.7 billion in funded debt and completes the first-ever dual proceeding under the U.S. bankruptcy code and Dutch restructuring law in 71 daysIn the first-ever cross border restructuring involving dual main proceedings under chapter 11 of the U.S. Bankruptcy Code and a scheme of arrangement (the "Dutch Scheme") under the Dutch Act on Confirmation of Extrajudicial Plans (Wet Homologatie Onderhands Akkoord ("WHOA")), and the first-ever chapter 15 recognition of Dutch Scheme proceedings and a sanctioned WHOA reorganization plan (the "WHOA Plan"), Jones Day represented Diebold Nixdorf, Incorporated ("Diebold") and certain of its U.S. and Canadian subsidiaries (the "Debtors") in connection with (i) the prepackaged chapter 11 cases of In re Diebold Holding Company, LLC, et al., (Case No. 23-90602-DRJ) commenced on June 1, 2023, in the United States Bankruptcy Court for the Southern District of Texas (the "Bankruptcy Court"); (ii) the Dutch Scheme, commenced on June 1, 2023 by Diebold Nixdorf Dutch Holding B.V. (the "Dutch Issuer") in the District Court of Amsterdam (the "Dutch Court"), and (iii) the chapter 15 proceedings before the Bankruptcy Court commenced by the foreign representative of the Dutch Issuer, wherein the Bankruptcy Court recognized the Dutch Scheme proceeding as a foreign main proceeding and recognized and extended comity to the WHOA Plan that was sanctioned by the Dutch Court.
  • Affinity Partners leads €207 million Series F financing of EGYMJones Day represented Affinity Partners in its acquisition of an interest in EGYM, a global fitness technology and corporate health innovation leader, in a Series F financing of €107 million, with an additional €100 million available for future investments.
  • Webster Bank provides $25 million credit facility to research and archiving service provider in biopharmaceutical industryJones Day represented Webster Bank, N.A. as administrative agent, collateral agent, swingline lender, issuing bank, and as a lender, in connection with a $25 million credit facility to a certain group of borrowers and their subsidiaries which provide research and archiving services in the biopharmaceutical industry.
  • Diebold Nixdorf obtains $1.25 billion senior secured superpriority DIP credit facilityJones Day is representing Diebold Nixdorf, Incorporated (the “Company”), a multinational financial and retail technology company that specializes in the sale, manufacture, installation, and service of self-service transaction systems (such as ATMs and currency processing systems), point-of-sale terminals, physical security products, and software and related services for global financial, retail, and commercial markets, and certain of its domestic and foreign subsidiaries (collectively, the “Debtors”) in (i) a pre-packaged chapter 11 proceeding in front of the U.S. Bankruptcy Court for the Southern District of Texas (the “Bankruptcy Court”), (ii) a scheme of arrangement by Diebold Nixdorf Dutch Holding B.V. (the “Dutch Issuer”) and the related voluntary proceeding in front of the District Court of Amsterdam under the Dutch Act on Confirmation of Extrajudicial Plans (Wet Homologatie Onderhands Akkoord), and (iii) an anticipated proceeding commenced by the Dutch Issuer under chapter 15 in the Bankruptcy Court, seeking recognition of such scheme of arrangement.
  • Stellex completes buyout of David Brown Santasalo GroupJones Day advised Stellex Capital Management LLC on its buyout of DB Santasalo S.à r.l from N4 Partners.
  • Rejuvenate acquires entire business operations of cell transplants manufacturer co.don AktiengesellschaftJones Day advised Rejuvenate GmbH, a subsidiary of ReLive Biotechnologies, in connection with the acquisition of the business operations of co.don Aktiengesellschaft ("CO.DON") (including all shares in its Dutch, UK and Swiss subsidiaries).
  • Belfius Bank, ING Belgium, and KBC Bank refinance Customer Collective groupJones Day acted as legal counsel to Belfius Bank NV/SA, ING Belgium NV/SA, and KBC Bank NV in connection with the refinancing of the Customer Collective group.
  • ArchiMed acquires PlasmidFactoryJones Day advised ArchiMed, a leading trans-atlantic private equity healthcare specialist, on its acquisition of PlasmidFactory, a globally renowned high-quality producer of plasmid DNA with strong research capabilities, from IP due diligence to structuring of acquisition and rollover re-investment.
  • Plastic Omnium acquires ams OSRAM Automotive Lighting Systems from ams OSRAM GroupJones Day advised Plastic Omnium in the acquisition of the Automotive Lighting Systems (AMLS) business of ams OSRAM Group in a highly complex international carve-out transaction.
  • Bayerische Landesbank subsidiary Real IS buys Innovationspark KisselbergJones Day advised Bayerische Landesbank subsidiary Real IS AG in the acquisition of Innovationspark Kisselberg in Mainz from a joint venture between J. Molitor Immobilien GmbH and Mainzer Aufbaugesellschaft mbh (MAG).
  • Belfius Bank and BNP Paribas Fortis NV/SA provide revolving facility to SD Worx NVJones Day acted as legal counsel to Belfius Bank NV/SA and BNP Paribas Fortis NV/SA in connection with a revolving facility provided to SD Worx NV.
  • Cenntro Electric Group acquires majority interest in Tropos Motors Europe GmbHJones Day advised Cenntro Electric Group Limited, a leading EV technology company with advanced, market-validated electric commercial vehicles, in the acquisition of a 65% equity interest in Tropos Motors Europe GmbH, a wholly owned subsidiary of Mosolf SE & Co. KG.
  • Solmax acquires U.S. geosynthetics manufacturer PropexJones Day served as antitrust and financing counsel to Groupe Solmax Inc. (Solmax) in the acquisition by Solmax of Propex Operating Company, LLC, a leading geosynthetics manufacturer with a long track record in the construction, transportation, mining, and automotive industries.
  • Buysse & Partners refinances Copus GroupJones Day acted as legal counsel to Buysse & Partners in connection with the global refinancing of one of its portfolio companies, the Copus Group, a group of HR agencies operating under different brands (such as Vivaldis, Seal Jobs, Heads & Hunters, Primus, Bennet, Eniteq, and Smart Solutions) followed by the add-on and accession of a Belgian company and two German entities as obligors.
  • KBC Bank and BNP Paribas provide financing to WVT group, a Sofindev portfolio company, for acquisition of Chemtec ChemicalsJones Day assisted the consortium of lenders, consisting of KBC Bank NV/SA and BNP Paribas Fortis, in connection with financing of the acquisition of Chemtec Chemicals GmbH by the WVT Group, a portfolio company of Sofindev.
  • ebase GmbH acquires securities business of Augsburger AktienbankJones Day advised European Bank of Financial Services GmbH (ebase) in the acquisition of the securities business of Augsburger Aktienbank AG.
  • ArchiMed acquires Cube Biotech GmbHJones Day advised ArchiMed, a leading Trans-Atlantic private equity healthcare specialist, on its acquisition of Cube Biotech GmbH, a leading provider of expression, purification, and crystallization services and products for membrane proteins.
    • View All

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.